SEC ownership of Amphastar Pharmaceuticals, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001297184.

Comparable stake leader

Jack Y. Zhang

Disclosed value leader

Jack Y. Zhang

Comparable rows

50/50

Latest evidence

07 Aug 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Jack Y. Zhang
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
07 Aug 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001297184
Issuer location
Rancho Cucamonga, CA

Ownership snapshot

Top shareholders of Amphastar Pharmaceuticals, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Jack Y. Zhang
Disclosed value leader
Jack Y. Zhang
Comparable rows
50/50
Latest evidence
07 Aug 2026
13D/G 3/4/5 13F Lead comparable stake: 25% 13D/G row: Jack Y. Zhang Showing 1-8 of 50 holder rows.

Quick read

Jack Y. Zhang leads the comparable SEC ownership view at 25%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Jack Y. Zhang's linked filing trail.
Comparable ownership Top 5
Jack Y. Zhang 25%
BlackRock, Inc. 12%
DIMENSIONAL FUND ADVISORS LP 5.2%
William J. Peters 0.39%
Floyd F. Petersen 0.16%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Jack Y. Zhang
13D/G 3/4/5
CEO & CHIEF SCIENTIFIC OFFICER, Director, 10%+ Owner
25%
$301,456,363
12,524,153 shares
$0 31 Dec 2024
BlackRock, Inc.
13D/G 13F
Company
12%
$142,136,789
5,333,463 shares
$0 30 Sep 2025
DIMENSIONAL FUND ADVISORS LP
13F 13D/G
Company
5.2%
from 13D/G
$46,519,189
2,305,107 shares
30 Jun 2026
William J. Peters
3/4/5
CFO, EVP & TREASURER, Director
0.39%
$3,885,578
172,846 shares
-$183,886 07 Aug 2026
Floyd F. Petersen
3/4/5
Director
0.16%
$1,850,044
71,368 shares
-$591,072 11 Dec 2025
STATE STREET CORP
13F
Company
13F
3.7%
$33,138,103
1,642,126 shares
30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
3.3%
$29,905,791
1,481,952 shares
30 Jun 2026
AMERICAN CENTURY COMPANIES INC
13F
Company
13F
2.7%
$23,744,313
1,176,626 shares
30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$1,306,443.

Buys
$0
Insiders: 0
Sells
$1,306,443
Insiders: 4
Net
-$1,306,443
Shares: -52,461
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 52,461
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 16,153 $0 $345,738 -$345,738
3-6 0 0 $0 $0 $0
6-9 0 18,129 $0 $477,141 -$477,141
9-12 0 18,179 $0 $483,564 -$483,564

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-15 of 15 reporting-owner rows connected to Amphastar Pharmaceuticals, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
15
Largest Forms 3/4/5 holder
Jack Y. Zhang
Net 12M change
-$1,306,442
Latest report
11 Aug 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Jack Y. Zhang CEO & CHIEF SCIENTIFIC OFFICER, Director, 10%+ Owner $112,189,838 Mixed 15 Mar 2026
Mary Z. Luo COO,Chief Scientist & Chairman, Director, 10%+ Owner $63,239,930 Mixed 10 Jan 2024
Richard Koo Director $15,350,254 Mixed 07 Jun 2021
Rong Zhou Senior Evp, Production Center $4,676,915 -$256,379 -5.2% Mixed 15 Mar 2026
William J. Peters CFO, EVP & TREASURER, Director $3,885,578 -$183,886 -4.5% Filing P/S 07 Aug 2026
Yakob Liawatidewi EVP CORP ADMIN CENTER, Director $3,294,057 Mixed 15 Mar 2026
Howard Lee Director $3,121,666 Mixed 01 Jun 2026
Floyd F. Petersen Director $1,850,044 -$591,072 -24% Filing P/S 11 Dec 2025
David Maris Director $1,092,746 Mixed 07 Jun 2021
Michael A. Zasloff Director $737,896 Mixed 01 Jun 2026
Diane G. Gerst Director $624,901 Mixed 01 Jun 2026
Richard K. Prins Director $601,387 -$275,105 -31% Filing P/S 11 Aug 2026
Gayle Deflin Director $373,326 Mixed 01 Jun 2026
David Russell Gaugh Director $283,016 Mixed 01 Jun 2026
Pierce Anthony T. Director $159,140 Median 09 Jul 2026

Recent insider transactions for Amphastar Pharmaceuticals, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Richard K. Prins AMPH Common Stock Sale -21.2% $161,852 $20.30 -7,973 29,625 11 Aug 2026 Direct
William J. Peters AMPH Common Stock Sale -4.52% $183,886 $22.48 -8,180 172,846 07 Aug 2026 Direct
William J. Peters AMPH Common Stock Options Exercise 2.87% 5,053 181,026 07 Aug 2026 Direct
William J. Peters AMPH Employee Stock Option (right to buy) Options Exercise -100% -5,053 0 07 Aug 2026 Direct
Pierce Anthony T. AMPH Common Stock Award 7,886 7,886 09 Jul 2026 Direct
Pierce Anthony T. AMPH Stock Option (right to buy) Award 16,646 16,646 09 Jul 2026 Direct
Howard Lee AMPH Common Stock Tax liability -0.48% -769 159,350 02 Jun 2026 Direct
Richard K. Prins AMPH Common Stock Award 27.6% 8,143 37,598 01 Jun 2026 Direct
Richard K. Prins AMPH Stock Option (right to buy) Award 17,365 17,365 01 Jun 2026 Direct
Howard Lee AMPH Common Stock Award 5.36% 8,143 160,119 01 Jun 2026 Direct
Howard Lee AMPH Stock Option (right to buy) Award 17,365 17,365 01 Jun 2026 Direct
Michael A. Zasloff AMPH Common Stock Award 27.6% 8,143 37,667 01 Jun 2026 Direct
Michael A. Zasloff AMPH Common Stock Award 17,365 17,365 01 Jun 2026 Direct
Diane G. Gerst AMPH Common Stock Award 34.3% 8,143 31,899 01 Jun 2026 Direct
Diane G. Gerst AMPH Stock Option (right to buy) Award 17,365 17,365 01 Jun 2026 Direct
David Russell Gaugh AMPH Common Stock Award 129.2% 8,143 14,447 01 Jun 2026 Direct
David Russell Gaugh AMPH Stock Option (right to buy) Award 17,365 17,365 01 Jun 2026 Direct
Gayle Deflin AMPH Common Stock Award 74.6% 8,143 19,057 01 Jun 2026 Direct
Gayle Deflin AMPH Stock Option (right to buy) Award 17,365 17,365 01 Jun 2026 Direct
Yakob Liawatidewi AMPH Common Stock Tax liability -0.84% -1,033 121,892 15 Mar 2026 Direct
Rong Zhou AMPH Common Stock Tax liability -0.71% -1,225 171,554 15 Mar 2026 Direct
William J. Peters AMPH Common Stock Tax liability -1.11% -1,973 175,063 15 Mar 2026 Direct
Jack Y. Zhang AMPH Common Stock Tax liability -0.23% -2,908 1,245,125 15 Mar 2026 See footnote
Jack Y. Zhang AMPH Common Stock Tax liability -0.33% -9,784 2,990,052 15 Mar 2026 Direct
William J. Peters AMPH Common Stock Tax liability -1.83% -3,297 177,036 10 Mar 2026 Direct
Rong Zhou AMPH Common Stock Tax liability -1.27% -2,215 172,779 10 Mar 2026 Direct
Yakob Liawatidewi AMPH Common Stock Tax liability -1.5% -1,870 122,925 10 Mar 2026 Direct
Jack Y. Zhang AMPH Common Stock Tax liability -0.35% -4,395 1,248,033 10 Mar 2026 See footnote
Jack Y. Zhang AMPH Common Stock Tax liability -0.49% -14,785 2,999,836 10 Mar 2026 Direct
William J. Peters AMPH Common Stock Award 48.2% 58,693 180,333 09 Mar 2026 Direct
William J. Peters AMPH Employee Stock Option (right to buy) Award 121,071 121,071 09 Mar 2026 Direct
Rong Zhou AMPH Common Srock Award 29.1% 39,432 174,994 09 Mar 2026 Direct
Rong Zhou AMPH Employee Stock Option (right to buy) Award 81,341 81,341 09 Mar 2026 Direct
Yakob Liawatidewi AMPH Common Stock Award 39.7% 35,450 124,795 09 Mar 2026 Direct
Yakob Liawatidewi AMPH Employee Stock Option (right to buy) Award 73,126 73,126 09 Mar 2026 Direct
Jack Y. Zhang AMPH Common Stock Award 6.14% 72,462 1,252,428 09 Mar 2026 See footnote
Jack Y. Zhang AMPH Common Stock Award 6.37% 180,504 3,014,621 09 Mar 2026 Direct
Jack Y. Zhang AMPH Employee Stock Option (right to buy) Award 149,472 149,472 09 Mar 2026 See footnote
Jack Y. Zhang AMPH Employee Stock Option (right to buy) Award 372,338 372,338 09 Mar 2026 Direct
William J. Peters AMPH Common Stock Tax liability -1.73% -2,146 121,640 06 Mar 2026 Direct
Rong Zhou AMPH Common Stock Tax liability -0.99% -1,357 135,562 06 Mar 2026 Direct
Yakob Liawatidewi AMPH Common Stock Tax liability -1.26% -1,144 89,345 06 Mar 2026 Direct
Jack Y. Zhang AMPH Common Stock Tax liability -0.26% -3,077 1,179,966 06 Mar 2026 See footnote
Jack Y. Zhang AMPH Common Stock Tax liability -0.27% -7,773 2,834,117 06 Mar 2026 Direct
Jack Y. Zhang AMPH Common Stock Tax liability -0.21% -2,432 1,183,043 04 Mar 2026 See footnote
Jack Y. Zhang AMPH Common Stock Tax liability -0.2% -5,769 2,841,890 04 Mar 2026 Direct
Rong Zhou AMPH Common Stock Tax liability -0.81% -1,124 136,919 04 Mar 2026 Direct
Yakob Liawatidewi AMPH Common Stock Tax liability -1.06% -965 90,489 04 Mar 2026 Direct
William J. Peters AMPH Common Stock Tax liability -1.39% -1,744 123,786 04 Mar 2026 Direct
Rong Zhou AMPH Common Stock Sale -6.62% $256,379 $26.20 -9,787 138,043 17 Dec 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .